312 related articles for article (PubMed ID: 25339095)
1. Interleukin-2-inducible T-cell kinase (ITK) deficiency - clinical and molecular aspects.
Ghosh S; Bienemann K; Boztug K; Borkhardt A
J Clin Immunol; 2014 Nov; 34(8):892-9. PubMed ID: 25339095
[TBL] [Abstract][Full Text] [Related]
2. Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation.
Huck K; Feyen O; Niehues T; Rüschendorf F; Hübner N; Laws HJ; Telieps T; Knapp S; Wacker HH; Meindl A; Jumaa H; Borkhardt A
J Clin Invest; 2009 May; 119(5):1350-8. PubMed ID: 19425169
[TBL] [Abstract][Full Text] [Related]
3. When to suspect inborn errors of immunity in Epstein-Barr virus-related lymphoproliferative disorders.
Sacco KA; Notarangelo LD; Delmonte OM
Clin Microbiol Infect; 2023 Apr; 29(4):457-462. PubMed ID: 36209991
[TBL] [Abstract][Full Text] [Related]
4. Inherited Interleukin 2-Inducible T-Cell (ITK) Kinase Deficiency in Siblings With Epidermodysplasia Verruciformis and Hodgkin Lymphoma.
Youssefian L; Vahidnezhad H; Yousefi M; Saeidian AH; Azizpour A; Touati A; Nikbakht N; Hesari KK; Adib-Sereshki MM; Zeinali S; Mansoori B; Jazayeri A; Karamzadeh R; Fortina P; Jouanguy E; Casanova JL; Uitto J
Clin Infect Dis; 2019 May; 68(11):1938-1941. PubMed ID: 30778533
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-2-Inducible T-Cell Kinase Deficiency-New Patients, New Insight?
Ghosh S; Drexler I; Bhatia S; Adler H; Gennery AR; Borkhardt A
Front Immunol; 2018; 9():979. PubMed ID: 29867957
[TBL] [Abstract][Full Text] [Related]
6. Management of XLP-1 and ITK deficiency: The challenges posed by PID with an unpredictable spectrum of disease manifestations.
Shadur B; Abuzaitoun O; NaserEddin A; Even-Or E; Zaidman I; Stepensky P
Clin Immunol; 2019 Jan; 198():39-45. PubMed ID: 30572125
[TBL] [Abstract][Full Text] [Related]
7. High incidence of Epstein-Barr virus (EBV)-positive Hodgkin lymphoma and Hodgkin lymphoma-like B-cell lymphoproliferations with EBV latency profile 2 in children with interleukin-2-inducible T-cell kinase deficiency.
Bienemann K; Borkhardt A; Klapper W; Oschlies I
Histopathology; 2015 Nov; 67(5):607-16. PubMed ID: 25728094
[TBL] [Abstract][Full Text] [Related]
8. IL-2-inducible T-cell kinase deficiency with pulmonary manifestations due to disseminated Epstein-Barr virus infection.
Mansouri D; Mahdaviani SA; Khalilzadeh S; Mohajerani SA; Hasanzad M; Sadr S; Nadji SA; Karimi S; Droodinia A; Rezaei N; Linka RM; Bienemann K; Borkhardt A; Masjedi MR; Velayati AA
Int Arch Allergy Immunol; 2012; 158(4):418-22. PubMed ID: 22487848
[TBL] [Abstract][Full Text] [Related]
9. [The understanding of Epstein-Barr virus associated lymphoproliferative disorder].
Zhou XG; Zhang YL; Xie JL; Huang YH; Zheng YY; Li WS; Chen H; Liu F; Pan HX; Wei P; Wang Z; Hu YC; Yang KY; Xiao HL; Wu MJ; Yin WH; Mei KY; Chen G; Yan XC; Meng G; Xu G; Li J; Tian SF; Zhu J; Song YQ; Zhang WJ
Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):817-821. PubMed ID: 28056294
[TBL] [Abstract][Full Text] [Related]
10. Signaling pathways involved in the T-cell-mediated immunity against Epstein-Barr virus: Lessons from genetic diseases.
Latour S; Fischer A
Immunol Rev; 2019 Sep; 291(1):174-189. PubMed ID: 31402499
[TBL] [Abstract][Full Text] [Related]
11. Magnesium Restores Activity to Peripheral Blood Cells in a Patient With Functionally Impaired Interleukin-2-Inducible T Cell Kinase.
Howe MK; Dowdell K; Roy A; Niemela JE; Wilson W; McElwee JJ; Hughes JD; Cohen JI
Front Immunol; 2019; 10():2000. PubMed ID: 31507602
[TBL] [Abstract][Full Text] [Related]
12. Role of the IL-2 inducible tyrosine kinase ITK and its inhibitors in disease pathogenesis.
Lechner KS; Neurath MF; Weigmann B
J Mol Med (Berl); 2020 Oct; 98(10):1385-1395. PubMed ID: 32808093
[TBL] [Abstract][Full Text] [Related]
13. Loss-of-function mutations within the IL-2 inducible kinase ITK in patients with EBV-associated lymphoproliferative diseases.
Linka RM; Risse SL; Bienemann K; Werner M; Linka Y; Krux F; Synaeve C; Deenen R; Ginzel S; Dvorsky R; Gombert M; Halenius A; Hartig R; Helminen M; Fischer A; Stepensky P; Vettenranta K; Köhrer K; Ahmadian MR; Laws HJ; Fleckenstein B; Jumaa H; Latour S; Schraven B; Borkhardt A
Leukemia; 2012 May; 26(5):963-71. PubMed ID: 22289921
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus (EBV)-induced B-cell proliferative disorder after chemotherapy in a patient with hemophagocytic lymphohistiocytosis with associated EBV-induced T-cell proliferation.
Suzumiya J; Ohshima K; Kanda M; Kumagawa M; Nagano M; Hirata M; Nawa Y; Tamura K; Kikuchi M
Leuk Lymphoma; 2000 May; 37(5-6):593-604. PubMed ID: 11042520
[TBL] [Abstract][Full Text] [Related]
15. Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan.
Wang RC; Chang ST; Hsieh YC; Huang WT; Hsu JD; Tseng CE; Wang MC; Hwang WS; Wang J; Chuang SS
Int J Clin Exp Pathol; 2014; 7(5):2430-7. PubMed ID: 24966953
[TBL] [Abstract][Full Text] [Related]
16. ITK Gene Mutation: Effect on Survival of Children with Severe Hemophagocytic Lymphohistiocytosis.
Zheng F; Li J; Zha H; Zhang J; Zhang Z; Cheng F
Indian J Pediatr; 2016 Nov; 83(11):1349-1352. PubMed ID: 27056244
[TBL] [Abstract][Full Text] [Related]
17. Atypical Clinical Course in Pediatric Hodgkin Lymphoma: Association With Germline Mutations in Interleukin-2-inducible T-Cell Kinase.
Alme C; Satwani P; Alobeid B; Bhagat G; Kelly KM
J Pediatr Hematol Oncol; 2015 Oct; 37(7):507-8. PubMed ID: 26056787
[TBL] [Abstract][Full Text] [Related]
18. Systemic Epstein-Barr Virus-Positive T/NK Lymphoproliferative Diseases With
Ishimura M; Eguchi K; Shiraishi A; Sonoda M; Azuma Y; Yamamoto H; Imadome KI; Ohga S
Front Pediatr; 2019; 7():183. PubMed ID: 31231620
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr Virus in Inborn Immunodeficiency-More Than Infection.
Lino CNR; Ghosh S
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638238
[TBL] [Abstract][Full Text] [Related]
20. The ITK-SYK fusion oncogene induces a T-cell lymphoproliferative disease in mice mimicking human disease.
Dierks C; Adrian F; Fisch P; Ma H; Maurer H; Herchenbach D; Forster CU; Sprissler C; Liu G; Rottmann S; Guo GR; Katja Z; Veelken H; Warmuth M
Cancer Res; 2010 Aug; 70(15):6193-204. PubMed ID: 20670954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
